Stock Fundamentals

Company Information

Company Name
Mineralys Therapeutics, Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US6031701013
CIK: 0001933414
CUSIP: 603170101
Currency: USD
Full Time Employees: 76
Phone: 888 378 6240
Fiscal Year End: December
IPO Date: Feb 10, 2023
Description:

Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Address:

150 N. Radnor Chester Road, Radnor, PA, United States, 19087

Directors & Officers

Name Title Year Born
Mr. Jon Congleton President, CEO & Director 1963
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D. Founder & Executive Director 1977
Mr. Adam Scott Levy CFO & Secretary 1978
Dr. David M. Rodman M.D. Chief Medical Officer 1955
Mr. Jeffrey A. Munsie J.D. Chief Legal Officer 1977
Dr. Robert McKean Ph.D. Senior Vice President of CMC NA
Ms. Danielle Mahoney Senior Vice President of Quality Assurance NA
Ms. Jessica Ibbitson Executive Vice President of Operations NA
Mr. Eric J. Warren R.Ph. Chief Commercial Officer 1972
Ms. Tiffany Ellen Burt Senior Vice President of Medical Affairs NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 17, 2026 David Malcom Rodman N/A Sale 416.00 $31.33 $13.03K
Apr 15, 2026 David Malcom Rodman N/A Sale 6.35K $27.66 $175.59K
Apr 13, 2026 David Malcom Rodman N/A Sale 14.06K $26.54 $373.10K
Apr 13, 2026 Jon Congleton N/A Sale 15.73K $26.83 $422.04K
Apr 09, 2026 David Malcom Rodman N/A Sale 2.17K $27.38 $59.41K
Mar 31, 2026 Daphne Karydas N/A Sale 3.00K $25.00 $75.00K
Mar 31, 2026 Jon Congleton N/A Sale 75.00K $26.27 $1.97M
Mar 27, 2026 Ra Capital Management, L.P. N/A Purchase 310.70K $23.67 $7.35M
Mar 13, 2026 David Malcom Rodman N/A Sale 14.06K $26.26 $369.16K
Mar 12, 2026 David Malcom Rodman N/A Sale 6.35K $27.37 $173.74K
Mar 09, 2026 David Malcom Rodman N/A Sale 2.17K $26.84 $58.27K
Feb 17, 2026 David Malcom Rodman N/A Sale 417.00 $27.59 $11.51K
Feb 13, 2026 David Malcom Rodman N/A Sale 14.06K $27.44 $385.67K
Feb 12, 2026 David Malcom Rodman N/A Sale 6.35K $28.99 $184.06K
Feb 09, 2026 David Malcom Rodman N/A Sale 2.17K $30.21 $65.59K
Jan 20, 2026 David Malcom Rodman N/A Sale 416.00 $32.10 $13.35K
Jan 14, 2026 David Malcom Rodman N/A Sale 11.37K $32.61 $370.68K
Jan 13, 2026 David Malcom Rodman N/A Sale 7.71K $32.75 $252.47K
Jan 12, 2026 Adam Scott Levy N/A Sale 10.76K $32.14 $345.76K
Jan 12, 2026 Jon Congleton N/A Sale 16.24K $32.62 $529.62K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Catalys Pacific LLC 7.90M Mar 31, 2026 9.58% $92.81 0.00%
RA Capital Management, LLC 7.69M Mar 31, 2026 9.32% $2.21 5.04%
Samsara BioCapital, LLC 5.87M Mar 31, 2026 7.12% $15.45 0.00%
FMR Inc 4.86M Mar 31, 2026 5.89% $0.01 -3.88%
BlackRock Inc 4.48M Mar 31, 2026 5.43% $0.00 3.56%
Wellington Management Company LLP 3.36M Mar 31, 2026 4.07% $0.02 328.31%
Vanguard Group Inc 3.35M Dec 31, 2025 4.06% $0.00 11.06%
State Street Corp 2.94M Mar 31, 2026 3.56% $0.00 -7.82%
Caligan Partners LP 2.77M Mar 31, 2026 3.36% $5.00 0.00%
LAURION CAPITAL MANAGEMENT LP 2.23M Mar 31, 2026 2.71% $2.64 30.26%
Orbimed Advisors, LLC 2.05M Mar 31, 2026 2.49% $1.10 109.39%
Point72 Asset Management, L.P. 1.91M Mar 31, 2026 2.32% $0.07 58.33%
Franklin Resources Inc 1.78M Mar 31, 2026 2.16% $0.01 -0.23%
Andera Partners 1.59M Mar 31, 2026 1.93% $24.38 0.00%
SR ONE CAPITAL MANAGEMENT, LP 1.56M Dec 31, 2025 1.90% $8.03 -26.02%
Suvretta Capital Management, LLC 1.54M Mar 31, 2026 1.87% $1.06 0.00%
Polar Capital Holdings PLC 1.50M Mar 31, 2026 1.82% $0.14 7.11%
T. Rowe Price Associates, Inc. 1.34M Mar 31, 2026 1.63% $0.00 1.37%
Sphera Funds Management Ltd. 1.34M Mar 31, 2026 1.62% $5.76 198.43%
Geode Capital Management, LLC 1.30M Mar 31, 2026 1.58% $0.00 3.46%

Shares Statistics

Shares Outstanding: 82.50M
Shares Float: 60.37M
% Insiders: 71.60%
% Institutions: 11,683.90%
Short % Float: 13.28%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 State Street® SPDR® S&P® Biotech ETF 1.98M 2.40% ▼ 0.71% Apr 30, 2026
2 Vanguard Health Care Inv 1.86M 2.25% ▲ 0.00% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.78M 2.16% ▲ 0.23% Apr 30, 2026
4 Polar Capital Biotech S Inc 1.42M 1.72% ▲ 0.00% Apr 30, 2026
5 iShares Russell 2000 ETF 1.12M 1.36% ▲ 0.85% Apr 30, 2026
6 Fidelity Select Health Care 1.00M 1.21% ▲ 0.00% Mar 31, 2026
7 Franklin Biotechnology Discv A(acc)USD 983.24K 1.19% ▼ 8.45% Apr 30, 2026
8 HBM Healthcare Investments AG Ord 781.86K 0.95% ▼ 24.21% Mar 31, 2026
9 American Century U.S. Small Cap Growth 679.60K 0.82% ▼ 4.69% Mar 31, 2026
10 American Century Small Cap Growth Inv 679.60K 0.82% ▼ 4.69% Mar 31, 2026

Valuation Metrics

Enterprise Value: $1.92B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.07B
EBITDA: $-171.45M
Book Value: $7.93
Earnings/Share: $-1.97
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -21.27%
ROE (TTM): -30.99%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 43.76x 0.00x 0.02x N/A 0.00x
2024-12-31 14.02x 0.00x 0.07x N/A 0.00x
2023-12-31 23.76x 0.00x 0.04x N/A 0.00x
2022-12-31 13.98x 0.00x 1.46x -18.78x 0.00x
2021-12-31 2.20x 0.00x 3.06x -693.52x 0.00x
2020-12-31 0.29x -1.25x 3.42x -25.59x -1.36x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MLYS.US!